Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
36.70    0.10 (0.27%)
Bid:
36.00
Ask:
37.40
Spread: 1.40 (3.889%)
Market Cap: £26.94m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Interim Management Statement

16 Aug 2010 07:00

RNS Number : 0884R
Carclo plc
16 August 2010
 



16 August 2010

 

Carclo plc

("Carclo" or "the Group")

 

Interim Management Statement

 

The board is pleased to announce that the new financial year has started well, particularly in the Technical Plastics division, and the group continues to trade in line with its expectations for the full year.

 

Technical Plastics has experienced good levels of demand compared to the same period last year. Volumes in our US medical business have recovered strongly and our other operations are all performing well.

 

In Precision Products, supercar lighting programmes at Wipac are progressively entering production and will contribute to much stronger trading in the second half. Our aerospace operations have not yet seen any significant increase in sales, although order intake is now rising and the businesses are performing satisfactorily.

 

Progress at Conductive Inkjet Technology ("CIT") has been good. In printed electronics, InkJetFlex sales are now growing and we have recently received production orders for specialised RFID tags developed by our customer in Asia on a MetalJet 600 facility. The Fine Line Technology touch sensor project with Atmel continues to build momentum. The complete production line will have been installed at CIT's facility in Cambridge by early autumn and validation of the manufacturing process and yield should follow soon after. Volume production is expected to commence in early 2011.

 

We expect the group's trading pattern in this financial year to be similar to the prior year with a greater proportion of operating profits generated in the second half of the year than in the first half.

 

The economic environment remains uncertain and yet our businesses are performing well and the group's financial position remains strong. The group is well placed to enjoy continued growth in its medical diagnostics, LED optics and lighting businesses as well as having exciting prospects at Conductive Inkjet Technology.

 

- ENDS -

 

Enquiries:

Carclo plc

01924 268040

Ian Williamson, Chief Executive

Robert Brooksbank, Finance Director

Weber Shandwick Financial

020 7067 0700

Nick Oborne / Stephanie Badjonat / Clare Thomas

 

Notes to editors

 

·; Carclo plc is a global supplier of technical plastic components. It is a public company whose shares are quoted on the London Stock Exchange.

 

·; Two thirds of sales are derived from the supply of fine tolerance, injection moulded plastic components, which are used in medical, optical and electronics products. This business, Carclo Technical Plastics, operates internationally in a fast growing and dynamic market underpinned by rapid technological development.

 

·; One third of sales are derived from the supply of specialised precision products to the premium automotive and aerospace industries.

 

·; Carclo's strategy is to develop new technologies and products to drive future growth.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUGPRUPUGQW
Date   Source Headline
27th Apr 20217:00 amRNSFull Year Trading Update
22nd Apr 20219:13 amRNSHolding(s) in Company
25th Feb 202110:32 amRNSHolding(s) in Company
24th Feb 202110:31 amRNSHolding(s) in Company
22nd Feb 202110:28 amRNSHolding(s) in Company
18th Feb 202111:19 amRNSHolding(s) in Company
12th Feb 20217:00 amRNSAppointment of Director and CFO
5th Feb 20217:00 amRNSDirector/PDMR Shareholding
4th Feb 20214:35 pmRNSPrice Monitoring Extension
4th Feb 20214:15 pmRNSDirector/PDMR Shareholding
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20217:00 amRNSDirector Appointment
8th Jan 20217:00 amRNSDirector Appointment
7th Jan 202111:35 amRNSDirector/PDMR Shareholding
5th Jan 20214:40 pmRNSDirector/PDMR Shareholding
23rd Dec 20207:00 amRNSFramework Agreement
15th Dec 202010:07 amRNSAppointment of Interim CFO
27th Nov 20207:01 amRNSBoard Changes
27th Nov 20207:00 amRNSHalf Year Results
26th Nov 20204:41 pmRNSSecond Price Monitoring Extn
26th Nov 20204:35 pmRNSPrice Monitoring Extension
12th Nov 20204:33 pmRNSNotice of Interim Results
10th Nov 20204:41 pmRNSSecond Price Monitoring Extn
10th Nov 20204:36 pmRNSPrice Monitoring Extension
5th Oct 20207:00 amRNSBoard restructure
2nd Oct 20204:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20204:36 pmRNSPrice Monitoring Extension
30th Sep 20207:00 amRNSAppointment of Non-Executive Chairman
29th Sep 202012:18 pmRNSResult of AGM
4th Sep 202011:04 amRNS2020 Annual Report & Accounts & Notice of 2020 AGM
25th Aug 20204:46 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSPreliminary Results for the year ended 31 March 20
18th Aug 20207:00 amRNSAppointment of NED and Chairman-elect
17th Aug 20207:00 amRNSUpdate on refinancing and current trading
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:35 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSFull Year Trading Statement and COVID-19 Update
1st May 20204:24 pmRNSHolding(s) in Company
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:37 pmRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSAppointment of Chairman
14th Apr 20202:41 pmRNSExternal Auditor Appointment
8th Apr 20202:39 pmRNSHolding(s) in Company
8th Apr 20209:03 amRNSHolding(s) in Company
6th Apr 20201:35 pmRNSHolding(s) in Company
3rd Apr 202011:40 amRNSHolding(s) in Company
30th Mar 20204:40 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.